Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
2.180
-0.170 (-7.23%)
Nov 5, 2024, 1:05 PM EST - Market open
Envoy Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Envoy Medical stock have an average target of 7.92, with a low estimate of 6.00 and a high estimate of 9.00. The average target predicts an increase of 263.30% from the current stock price of 2.18.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Envoy Medical stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 3 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Brookline Capital | Brookline Capital | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +312.84% | Oct 14, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $8.5 → $8.75 | Strong Buy | Maintains | $8.5 → $8.75 | +301.38% | Sep 3, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $8.5 | Strong Buy | Initiates | $8.5 | +289.91% | Jun 24, 2024 |
| Lake Street | Lake Street | Strong Buy Maintains $3 → $6 | Strong Buy | Maintains | $3 → $6 | +175.23% | Apr 3, 2024 |
| Northland Capital Markets | Northland Capital Markets | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 21, 2023 |
Financial Forecast
Revenue This Year
290.36K
from 316.00K
Decreased by -8.11%
Revenue Next Year
340.00K
from 290.36K
Increased by 17.09%
EPS This Year
-1.10
from -2.38
EPS Next Year
-1.14
from -1.10
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 315,000 | 420,000 | 672,000 |
| Avg | 290,363 | 339,997 | 652,800 |
| Low | 271,460 | 294,000 | 627,200 |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.3% | 44.6% | 97.6% |
| Avg | -8.1% | 17.1% | 92.0% |
| Low | -14.1% | 1.3% | 84.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.12 | -1.10 | -0.59 |
| Avg | -1.10 | -1.14 | -0.57 |
| Low | -1.06 | -1.14 | -0.55 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.